Table 1.

Clinical and laboratory baseline characteristics of study participants.

Variable	N	Control			N	Rb			p-value
Sex (men/women)	24	9/15			24	7/17			0.54
Age (years)	24	31.92	±	8.05	24	32.46	±	10.12	0.83
BMI (kg/m2)	24	29.38	±	3.94	24	30.42	±	5.00	0.43
Waist circumference (cm)	24	98.10	±	11.81	24	98.53	±	13.32	0.90
Fasting glucose (mmol/L)	24	4.84	±	0.47	23	4.98	±	0.59	0.38
Fasting insulin (pmol/L)	22	73.91	±	33.57	19	83.11	±	43.54	0.21
HbA1C (%)	24	5.05	±	0.29	24	5.03	±	0.31	0.85
Plasma TG (mmol/L)	24	1.56	±	0.78	24	1.46	±	0.80	0.66
ApoB-100 (g/L)	24	0.88	±	0.17	24	0.92	±	0.24	0.48
HDL-C (mmol/L)	24	1.33	±	0.23	24	1.32	±	0.40	0.94
LDL-C (mmol/L)	24	2.55	±	0.74	24	2.65	±	0.86	0.69
CRP (mg/L)	24	2.72	±	2.82	23	2.68	±	2.34	0.95
HOMA-IR	13	1.78	±	0.76	11	2.84	±	1.73	0.06
MATSUDA	13	5.79	±	2.43	11	4.54	±	2.24	0.21

Data are means ± standard deviations. Sex is presented as counts. p-values were obtained by a general linear model, type III sum of squares, and chi-square tests (sex). BMI, body mass index. HbA1C, glycated hemoglobin. TG, triglycerides. ApoB-100, Apolipoprotein B. HDL-C, high-density lipoprotein cholesterol. LDL-C, low-density lipoprotein cholesterol. CRP, C-reactive protein. HOMA-IR, homeostatic model assessment of insulin resistance.